D-1306-2020 Class II Terminated
FDA drug recall D-1306-2020 was initiated by Pfizer Inc. on May 29, 2020 and is designated Class II. Reason for recall: Presence of Particulate Matter: particulate matter identified after reconstitution. The recall status is terminated (terminated Jan 13, 2022). Affected quantity: 94320 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 17, 2020
- Initiation Date
- May 29, 2020
- Termination Date
- Jan 13, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 94320 units
Product description
Unasyn (ampicillin sodium/sulbacatam) for injection, 1.5 g* per vial, Rx Only, 10 vials/carton, Made in Italy Distributed by Roerig Division of Pfizer Inc. New York, NY 10017 vial NDC 0049-0013-81, carton NDC 0049-0013-83
Reason for recall
Presence of Particulate Matter: particulate matter identified after reconstitution.
Distribution pattern
Distributed Nationwide in the US
Code information
Lot # 3301612, EXP 02/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1306-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.